Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026
Manufacturing and Production Celtic Renewables

Scottish green chemicals company Celtic Renewables is part of a consortium that has secured £7m in funding to support development …

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026
Research and Development Sophia Genetics, Synnovis

Synnovis and SOPHiA GENETICS have announced a collaboration to expand blood-based cancer testing for patients with lung and breast cancer …

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026
MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is establishing a new hub in Northern Ireland aimed at strengthening engagement …

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026
Manufacturing and Production Shilpa Medicare

Shilpa Medicare has entered into a long-term development and manufacturing agreement with Swiss biotech company NXI Therapeutics focused on an …

CGT Catapult backs AI platform for gene therapy delivery

May 12, 2026
Cell and Gene Therapy Catapult

Cell and Gene Therapy Catapult (CGT Catapult) is providing investment to UK biotech company Lir Therapeutics to support development of …

Campaign highlights low expectations among patients with depression

May 7, 2026
Johnson & Johnson, major depressive disorder (MDD)

A new global awareness campaign from Johnson & Johnson is aiming to encourage people with major depressive disorder (MDD) to …

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026
Manufacturing and Production AI, Made Smarter

A new guide from Made Smarter is helping manufacturers cut through the noise around AI and focus on what actually …

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026
Research and Development Syngene International

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Maninder Kapoor Puri as …

BioPhorum acquires PharmaX Solutions

May 5, 2026
Manufacturing and Production BioPhorum, PharmaX Solutions

BioPhorum has acquired PharmaX Solutions, a consultancy specialising in digital transformation and end-to-end digital manufacturing solutions across pharmaceutical manufacturing and …

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026
Research and Development Syngene International

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Abhijit Zutshi as Chief …

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026
Peptide therapies, peptide

Japanese pharmaceutical companies are increasingly engaging contract development and manufacturing organisations (CDMOs) earlier in the drug development process, as the …

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026
Research and Development fatty liver disease, phospholipid therapy

A randomised clinical trial has reported that treatment with essential phospholipids (Essentiale) may reduce liver fat and improve symptoms in …

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026
Neurology, mental health

The US Food and Drug Administration (FDA) has announced a series of measures aimed at supporting the development of psychedelic-based …

New web series explores path from ophthalmic research to patient access

April 28, 2026
Research and Development Opthalmology

A new YouTube web series has been launched to examine how ophthalmic innovations progress from early research through to approved …

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026
Research and Development The European Medicines Agency (EMA), plozasiran

The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Redemplo (plozasiran) to treat adults with familial chylomicronaemia …

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026
Research and Development SynaptixBio, neurodegenerative disease

SynaptixBio has highlighted the potential of speech analysis as a non-invasive way to track disease progression in neurodegenerative conditions, as …

Ofichem brings all brands under single trading name

April 23, 2026
Ofichem

Ofichem has brought all its brands under its trading name to provide its customers a single integrated offering. The company …

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026
Carvolix

Carvolix (formerly Affluent Medical) has announced it is strengthening its Board of Directors, advisory board and governance structure. As part …

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026
University of Huddersfield’s NHIC

Dr Zubir Ahmed MP, the Under-Secretary of State for Health Innovation and Safety, recently visited the newly opened Emily Siddon …

Incyclix Bio announces new additions to the Board

April 22, 2026
Incyclix Bio

Incyclix Bio has announced that it has raised $5m in additional funds for its Series B financing from new investor …

The Gateway to Local Adoption Series

Latest content